Localization of neurovirulence determinant for rats on the S1 subunit of murine coronavirus JHMV

Virology

Volumn 208, Issue 1, 1995, Pages 67-74

  Taguchi, Fumihiro ^a   Kubo, Hideyuki ^a   Takahashi, Hiromi ^a   Suzuki, Hideka ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0028955228     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1995.1130     Document Type: Article

References (44)

1. Banner, L. R., Keck, J. G., and Lai, M. M. C. (1990). A clustering of RNA recombination sites adjacent to a hypervariable region of the peplomer gene of murine coronavirus. Virology 175, 548-555.
2. Boursnell, M. E. G., Brown, T. D. K., Foulds, I. J., Green, P. F., Tomley, F. M., and Binns, M. M. (1987). Completion of the sequence of the genome of the coronavirus avian infectious bronchitis virus. J. Gen. Virol. 68, 57-77.
3. Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., and Rutter, W. J. (1979), Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294-5299.
4. Collins, A. R., Knobler, R. L., Powell, H., and Buchmeier, M. J. (1982). Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell fusion. Virology 119, 358-371.
5. Dalziel, R. G., Lampert, P. W., Talbot, P. J., and Buchmeier, M. J. (1986). Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulenoe, J. Virol. 59, 463-471.
6. Evans, D. M. A., Minor, P. D., Schild, G. C., and Almond, J. W. (1983), Critical role of an eight amino acid sequence of VP1 in neutralization of poliovirus type 3. Nature (London) 304, 459-462.
7. Fazakerley, J. K., Parker, S. E., Bloom, F., and Buchmeier, M. J. (1992). The V5A13.1 envelope glycoprotein deletion mutant of mouse hepatitis virus type-4 is neuroattenuated and has a reduced rate of spread in the central nervous system. Virology 187, 178-188.
8. Fleming, J. O., Trousdale, M. D., El-Zaatari, F. A. K., Stohlman, S. A., and Weiner, L. P. (1986). Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J. Virol. 58, 869-875.
9. Fleming, J. O., Trousdale, M. D., Bradbury, J., Stohlman, S. A., and Weiner, L P. (1987). Experimental demyelination induced by coronavirus JHM (MHV-4); Molecular identification of a viral determinant of paralytic disease. Microb. Pathog. 3, 9-20.
10. Gallagher, T. M., Parker, S. E., and Buchmeier, M. J. (1990). Neutralization-resistant variants of a neurotropic coronavirus are generated by deletion within the amino-terminal half of the spike glycoprotein. J. Virol. 64, 731-741.
11. Grosse, B., and Siddell, S. G. (1994). Single amino acid changes in the S2 subunit of the MHV surface glycoprotein confer resistance to neutralization by St-specific monoclonal antibody. Virology 202, 814-824.
12. Hirano, N., Murakami, T., Taguchi, F., Fujiwara, K., and Matumoto, M. (1981), Comparison of mouse hepatitis virus strains for pathogenicity in weanling mice infected by various routes. Arch. Virol 70, 69-73.
13. Holmes, K. V., Doller, E. W., and Behnke, J. N. (1981). Analysis of the function of coronavirus glycoprotein by differential inhibition of synthesis with tunicamycin. Adv. Exp. Med. Biol 142, 133-142.
14. Knossow, M., Daniels, R. S., Douglas, A. R., Skehel, J. J., and Wiley, D. C., (1984). Three-dimensional structure of an antigenic mutant of the influenza virus hemagglutinin. Nature (London) 311, 678-680.
15. Kubo, R., Takase, S. V., andTaguchi, F. (1993). Neutralization and fusion inhibition activities of monoclonal antibodies specific for the Si subunit of the spike protein of neurovirulent murine coronavirus iHMV ci-2 variant. J. Gen. Viroi. 74, 1421-1426.
16. Kubo, F. T., Yamada, Y. K., andTaguchi, F. (1994). Localization of neutralizing epitopes and receptor-binding site within the amino terminal 330 amino acids of murine coronavirus spike protein. J. Virol 68, 5403-5410.
17. Kyuwa, S., and Stohlman, S. A. (1990). Pathogenesis of a neurotropic murine coronavirus strain, JHM, in the central nervous system of mice. Sem. Virol. 1, 273-280.
18. Lavi, E., Murray, M., Makino, S., Stohlman, S. A., Lai, M. M. G., and Weiss, S. R. (1990). Determinants of coronavirus MHV pathogenesis are localized to 3’ portion of the genome as determined by ribonucleic acid-ribonucleic acid recombination. Lab. Invest. 62, 570-578.
19. Lee, F. L. L., Shieh, C. K., Gorbalenya, A. E., Eugene, E. V., La Monica, N., Tuler, J., Bagdzhadzhyan, A., and Lai, M. M. C. (1991). The complete sequence (22 kilobases) of murine coronavirus gene 1 encoding the putative protease and RNA polymerase. Virology 180, 567-582.
20. Matsubara, Y., Watanabe, R., andTaguchi, F. (1991). Neurovirulence of six different murine coronavirus JHMV variants ror rats. Vims Res. 20, 45-58.
21. Monica, N., Branner, L R., Morris, V. L., and Lai, M. M. C., (1991). Localization of extensive deletions in the structural genes of two neurotropic variants of murine coronavirus JHM. Virology 182, 883-888.
22. Morris, V. L., Tieszer, C., Mackinnon, J., and Percy, D. (1989). Characterization of coronavirus JHM variants isolated from Wistar Furth rats with a viral-induced demyei'mating disease. Virology 169, 127-136
23. Nagashima, K., Wege, H., Meyermann, R., and ter Meulen, V. (1978). Corona virus induced subacute demyelinating encephalomyelitis in rats. Acta Neuropathol IBeri 44, 63-70
24. Parker, S. E., Gallagher, T. M., and Buchmeier, M. J. (1989). Sequence analysis reveals extensive polymorphism and evidence of deletions within the E2 glycoprotein gene of several strains of murine hepatitis virus. Virology 173, 664-673.
25. Schmidt, I., Skinner, M., and Siddell, S. (1987). Nucleotide sequence of the gene encoding the surface projection glycoprotein of coronavirus MHV-JHM. J. Gen. Virol. 68, 47-56.
26. Seif, I., Coulon, P., Rollin, P. E., and Demand, A., (1985), Rabies virulence; Effect on pathogenicity and sequence characterization of rabies virus mutation affecting antigenic site III of the glycoprotein. J. Virol, 53, 926-934.
27. Siddell, S. G., Wege, H., and ter Meulen, V., (1983), The biology of coronaviruses. J. Gen. Virol. 64, 761-776
28. Spaan, W., Cavanagh, D., and Horzinek, M. C. (1988). Coronaviruses: Structure and genome expression. J. Gen. Virol. 69, 2939-2952.
29. Stauber, R., Pfleideror, M., and Siddell, S. (1993). Proteolytic cleavage ot the murine coronavirus surface glycoprotein is not required for fusion activity. J. Gen. Virol. 74, 183-191
30. Sturman, L. S., and Holmes, K. V. (1984). Proteolytic cleavage of peplomer glycoprotein E2 of MHV yields two 90 K subunits and activates cell fusion. Adv. Exp. Med. Biol. 173, 25-35.
31. Taguchi, F. (1993). Fusion formation by uncleaved spike protein of murine coronavirus JHMV variant cl-2. J. Virol. 67, 1195-1202.
32. Taguchi, F., and Fleming, J, O. (1989). Comparison of six different murine coronavirus JHM variants by monoclonal antibodies against the E2 glycoprotein, Virology 169, 233-235
33. Taguchi, F., Ikeda, T., and Shida, H. (1992). Molecular cloning and expression of a spike protein of neurovirulent murine coronavirus JHMV variant cl-2. J. Gen. Virol. 73, 1065-1072.
34. Taguchi, F., Massa, P., and ter Meulen, V. (1986). Characterization of a variant virus isolated from neural cell culture after infection of mouse coronavirus JHMV. Virology 155, 267-270.
35. Taguchi, F., Siddell, S. G., Wege, W., and ter Meulen, V. (1985). Characterization of a variant virus selected in rat brain after infection by coronavirus mouse hepatitis virus JHM, J. Virol. 54, 429-435.
36. Taguchi, F., Yamada, A., and Fujiwara, K. (1980). Resistance to highly virulent mouse hepatitis virus acquired by mice after low-virulence infection; Enhanced antiviral activity of macrophages, infect immun. 29, 42-49.
37. Wang, F. L., Fleming, J. O., and Lai, M. M. C. (1992). Sequence analysis of the spike protein gene of murine coronavirus variants-. Study of genetic sites affecting neuropathogenicity. Virology 186, 742-749.
38. Wege, H., Siddell, S. G., and ter Meulen, V, (1982), The biology and pathogenesis of coronavi ruses. Curr. Top. Microbiol. Immunol 99, 185-200.
39. Wege, H., Watanabe, R., and ter Meulen, V. (1984), Relapsing subacute demyelinating encephalomyelitis in rats during the course of coronavirus JHM infection, J. Neuroimmunol. 6, 325-336.
40. Wege, H., Winter, J., and Meyermann, R., (1988). The pepiomer protein E2 of coronavirus JHM as a determinant of neurovirulence; Definition of critical epitopes by variant analysis. J. Gen. Virol 69, 87-98.
41. Williams, R. K., Jiang, G. S., and Holmes, K. V., (1991). Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins. Proa Waff. Acad. Sci, USA 88, 5533-6536.
42. Winship, P. R. (1989). An improved method for directly sequencing PCR material using dimethyl sulfoxide. Nucleic Acids Res. 17, 12-66.
43. Yamada, Y. K., Abe, M., Yamada, A., and Taguchi, F. (1993). Detection of mouse hepatitis virus by the polymerase chain reaction and its application to the rapid diagnosis of infection. Lab. Anim. Sci. 43, 285-290.
44. Yokomori, K., Stohlman, S. A., and Lai, M. M. C., (1993). The detection and characterization of multiple hemagglutinin-esterase (HE)-defec-tive viruses in the mouse brain during subacute demyelination induced by mouse hepatitis virus. Virology 192, 170-178